| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.07. | Functional Brands Inc. - 8-K, Current Report | - | SEC Filings | ||
| 15.06. | Functional Brands faces Nasdaq delisting after stock falls below $0.10 | 2 | Investing.com | ||
| 15.06. | Functional Brands Inc.: Functional Brands Inc. Receives Nasdaq Staff Delisting Determination | 298 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - June 15, 2026) - Functional Brands Inc. (NASDAQ: MEHA) (the "Company"), a leading innovator in wellness and performance products, announced today that on June... ► Artikel lesen | |
| 15.06. | Functional Brands Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| FUNCTIONAL BRANDS Aktie jetzt für 0€ handeln | |||||
| 05.06. | Functional Brands Inc.: Functional Brands Inc. Announces Active Interest from Multiple Strategic Partners to Fund BullionFX | Alchemy Commercialization Following Pending Acquisition of the BFX Assets | 651 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - June 5, 2026) - Functional Brands Inc. (NASDAQ: MEHA) ("MEHA" or the "Company") today announced advanced discussions with multiple strategic financial parties... ► Artikel lesen | |
| 04.06. | Functional Brands Inc.: Functional Brands Inc. Enters BullionFX | Alchemy Acquisition From a Position of Improving Financial Strength | 554 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - June 4, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a U.S.-domiciled Nasdaq issuer, which is party to a binding agreement to acquire the assets of BullionFX... ► Artikel lesen | |
| 03.06. | Functional Brands shareholders approve reverse stock split | 4 | Investing.com | ||
| 03.06. | Functional Brands Inc.: Functional Brands Inc. Clears Barrier to $142.9 Million BullionFX | Alchemy Acquisition | 436 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - June 3, 2026) - Functional Brands Inc. (NASDAQ: MEHA), announced that shareholders have voted to authorize the reverse stock split, removing an obstacle between... ► Artikel lesen | |
| 28.05. | Functional Brands Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 28.05. | Functional Brands Inc.: Functional Brands Announces Adjournment of Special Meeting of Stockholders | 485 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - May 27, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced that the Company's Special... ► Artikel lesen | |
| 22.05. | Functional Brands to acquire BullionFX for $142.9M | 3 | Seeking Alpha | ||
| 22.05. | Functional Brands kündigt Übernahme von BullionFX-Assets im Wert von 142,9 Mio. US-Dollar an | 19 | Investing.com Deutsch | ||
| 22.05. | Functional Brands to acquire BullionFX assets for $142.9M | 2 | Investing.com | ||
| 22.05. | Functional Brands Inc.: Functional Brands Enters into Agreement to Acquire Alchemy, a Gold-Backed Blockchain Settlement Platform, in a $142.9 Million Transaction | 671 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - May 22, 2026) - Functional Brands Inc. (NASDAQ: MEHA) ("Functional Brands" or the "Company") today announced the execution of a definitive agreement for the... ► Artikel lesen | |
| 19.05. | Functional Brands informiert Aktionäre über mögliche Übernahme von BullionFX-Vermögenswerten | 1 | Investing.com Deutsch | ||
| 18.05. | Functional Brands Inc. GAAP EPS of -$0.36, revenue of $1.65M | 1 | Seeking Alpha | ||
| 18.05. | Functional Brands Inc.: Functional Brands Announces First Quarter 2026 Financial Results | 499 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - May 18, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced financial results for the... ► Artikel lesen | |
| 18.05. | Functional Brands Inc. - 8-K, Current Report | 7 | SEC Filings | ||
| 15.05. | Functional Brands Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 12.05. | Functional Brands modifies Series C preferred stock conversion terms | 2 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 50,26 | -0,87 % | Märkte am Morgen: Bayer, Deutsche Bank, SAP, Delivery Hero, Easyjet, ASML | Der DAX hat in der vergangenen Woche abgeliefert. Ein Plus von 4,5 Prozent bedeutet die beste Handelswoche seit April 2025. Vor allem an den letzten Tagen blies der DAX zur Rekordjagd, stellte eine... ► Artikel lesen | |
| MERCK KGAA | 138,95 | -0,47 % | Aktien Frankfurt Ausblick: Dax kaum bewegt nach Rekord | FRANKFURT (dpa-AFX) - Nach seinem Rekordlauf in der vergangenen Woche dürfte der Dax am Montag seine Gewinne halten. Stützend wirken teils freundliche Aktienmärkte in Asien. Dort sorge die Aussicht... ► Artikel lesen | |
| PMGC | 1,110 | -0,89 % | PMGC Holdings Inc.: NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression | Independent flow cytometry (FACS) study will quantify latent myostatin antigen expression on NorthStrive-manufactured Lactobacillus casei and establish comparability against EL-22 material previously... ► Artikel lesen | |
| NOVO NORDISK | 43,280 | -0,22 % | Novo Nordisk: Kursziel rauf | Stück für Stück arbeitet sich die Aktie von Novo Nordisk aus dem Tal der Tränen. Zum Start in die neue Handelswoche verbucht das Papier des dänischen Biopharma-Konzerns an der Heimatbörse in Kopenhagen... ► Artikel lesen | |
| KAZIA THERAPEUTICS | 13,540 | -0,15 % | Kazia Therapeutics Limited: Kazia Therapeutics Appoints James Levine as Chief Financial Officer | SYDNEY, June 2, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia," "Kazia Therapeutics" or the "Company"), a clinical-stage oncology company... ► Artikel lesen | |
| BRIGHT MINDS BIOSCIENCES | 77,84 | 0,00 % | Motorola Solutions Foundation and Calculated Genius Honor Chicagoland Future Engineers With 2026 Bright Minds, Bold Futures Scholarship | NORTHAMPTON, MA / ACCESS Newswire / June 30, 2026 / Ten extraordinary Chicagoland high school seniors recently gathered at Motorola Solutions' global headquarters in Chicago, joined by family members... ► Artikel lesen | |
| KARDIGAN | 24,550 | -0,34 % | Jefferies initiates Kardigan stock with buy rating on cardiology pipeline | ||
| ETON PHARMACEUTICALS | 36,720 | +0,30 % | Eton Pharmaceuticals Aktie erreicht Rekordhoch von 38,6 USD | ||
| LB PHARMACEUTICALS | 32,950 | 0,00 % | LB Pharmaceuticals Inc: LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) | ||
| PFIZER | 21,270 | +0,35 % | JPMORGAN stuft PFIZER INC auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat das Kursziel für Pfizer von 30 auf 28 US-Dollar gesenkt und die Einstufung auf "Neutral" belassen. Seine Schätzungen für die Quartalszahlen am... ► Artikel lesen | |
| CHINA PHARMA HOLDINGS | 0,635 | 0,00 % | China Pharma: Keine Erklärung für ungewöhnliche Handelsaktivitäten | ||
| ELI LILLY | 1.041,60 | +0,06 % | Megatrend Folger: Eli Lilly sprengt die Billionen-Marke | Eli Lilly marschiert weiter an der Spitze des globalen Gesundheitssektors. Die Aktie des US-Pharmagiganten kletterte am Dienstag auf ein neues Allzeithoch und lässt damit die Marke von einer Billion... ► Artikel lesen | |
| VYNE THERAPEUTICS | 0,642 | +0,66 % | VYNE Therapeutics Inc.: VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience | NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company") today announced that its Board of Directors has declared a special cash dividend (the "Cash... ► Artikel lesen | |
| INHIBIKASE THERAPEUTICS | 2,040 | 0,00 % | Inhibikase Therapeutics Announces First Quarter 2026 Financial Results and Highlights Recent Activity | WILMINGTON, Del., May 12, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary... ► Artikel lesen | |
| ASTRAZENECA | 149,80 | -0,37 % | BERNSTEIN RESEARCH stuft ASTRAZENECA auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat das Kursziel für Astrazeneca von 18600 auf 18900 Pence angehoben und die Einstufung auf "Outperform" belassen. Vielversprechende... ► Artikel lesen |